Αναζήτηση

σε πρόσθεσε στο άλλο

2026-07-27 10:51:14 - Μετάφραση -

Erlotinib HCl Market Growth Outlook Driven by Rising Demand for Targeted Cancer Therapies

According to WiseGuy Reports, the Erlotinib HCl Market was valued at USD 2,113.7 million in 2024 and increased to USD 2,263.7 million in 2025. The market is anticipated to reach USD 4,500.0 million by 2035, registering a CAGR of 7.1% during the forecast period. Growth is supported by the increasing prevalence of cancer, rising adoption of targeted therapies, expanding clinical research, and...

0 Σχόλια 0 Μοιράστηκε 15 Views 0 Προεπισκόπηση